Tocagen Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for Toca 511 & Toca FC in Recurrent High Grade Gliomahttp://finance.yahoo.com/news/tocagen-receives-breakthrough-therapy-designation-130000791.html
More good news in the brain cancer research world. Progress continues forward.
Tocagen Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for Toca 511 & Toca FC in Recurrent High Grade Glioma
ReplyDeletehttp://finance.yahoo.com/news/tocagen-receives-breakthrough-therapy-designation-130000791.html
More good news in the brain cancer research world. Progress continues forward.
Delete